Jump to content

Drilldown: Medicines

Choose a table:


Medicines > classes : Analgesic or Barbiturate or Botanical

Use the filters below to narrow your results.

generic:
Codeine (2)
brand:
None (29) · (multiple, generic dominant) (1) · Amytal (1) · Brevital (1) · Darvon (1) · Demerol (1) · Dilaudid (1) · Dolophine (1) · Duragesic (1) · Luminal (1) · Nembutal (1) · Nubain (1) · Nucynta (1) · Opana (1) · Pentothal (1) · Seconal (1) · Stadol (1) · Suboxone (1) · Talwin (1) · Vicodin (1)
classes: (Click arrow to add another value)
mechanism:
None (2) · Apomorphine and nuciferine; dopaminergic activity (1) · Contains atropine, scopolamine, hyoscyamine (1) · Contains bufotenin and DMT (1) · Contains harmine, harmaline, tetrahydroharmine (1) · Contains ibogaine; kappa-opioid agonist (1) · Contains LSA (2) · Contains mescaline (2) · Contains muscimol and ibotenic acid (1) · Contains psilocybin and psilocin (1) · Contains salvinorin A (1) · DMT + MAOI (harmine/harmaline); 5-HT2A agonist (1) · DMT-containing plant used in psychedelic preparations (1) · GABAA potentiator and direct activator (3) · GABAA potentiator; ultra-short-acting (2) · Kappa agonist; mu antagonist (1) · Kappa agonist; mu partial agonist (1) · Kappa agonist; mu partial agonist/antagonist (1) · Kavalactones; GABAA modulator; sigma receptor activity (1) · Mechanism incompletely understood (1) · Mitragynine/7-hydroxymitragynine; mu-opioid partial agonist (1) · Mu-opioid agonist; norepinephrine reuptake inhibitor (1) · Mu-opioid receptor agonist (4) · Mu-opioid receptor agonist; NMDA antagonist (1) · Mu-opioid receptor agonist; prodrug (metabolized to morphine) (1) · Mu-opioid receptor agonist; sodium channel blocker (1) · Mu/kappa/delta agonist; NMDA antagonist (1) · Partial MAOI; anticholinergic effects (1) · Partial mu-opioid agonist; kappa antagonist (1) · Partial mu-opioid receptor agonist; alpha-2 agonist (1) · Phosphodiesterase inhibitor; calcium channel blocker (1) · Potent mu-opioid receptor agonist (4) · Prodrug; converted to [[Morphine|morphine]] by [[Enzyme:CYP2D6|CYP2D6]] for analgesic action. (1) · Reversible MAO-A inhibitor; beta-carboline (1) · Reversible MAO-A inhibitor; NMDA antagonist; beta-carboline (1) · Weak serotonin reuptake inhibitor; beta-carboline (1)
uses:
None (47) · Mild to moderate pain; cough suppression (low-dose). (1)
starting dose:
None (47) · Adult: 15–60 mg every 4 hours as needed. (1)
preparations:
None (47) · Tablet (15, 30, 60 mg); oral solution; combination products (with [[Acetaminophen|acetaminophen]] or ibuprofen). (1)
fda max:
None (47) · 360 mg/day (1)
routes:
None (47) · PO (only formulation marketed in the US). (1)
onset:
None (47) · 30–60 min (PO) (1)
duration:
None (47) · 4–6 hours (1)
halflife:
None (47) · 2.5–3 hours (1)
bioavailability:
None (47) · ~50% (variable, CYP2D6-dependent for analgesic effect). (1)
pregnancy:
None (47) · Avoid; risk of neonatal opioid withdrawal with chronic use; UM-mother breastfeeding contraindicated. (1)
legal:
None (47) · US Schedule II (single-entity); Schedule III–V (combination products by content). (1)

Showing below up to 48 results in range #1 to #48.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"